Ketamine Safety Profile: Side Effects, Risks, and Contraindications

Understanding the safety profile of any medical treatment is essential for making an informed decision. Ketamine has been used in medicine for over 50 years and is included on the World Health Organization's List of Essential Medicines due to its wide margin of safety.^[1] However, like all medications, it carries risks that must be understood and managed.

This page provides a comprehensive, evidence-based overview of ketamine's side effects, contraindications, drug interactions, and risk factors -- as well as the critical distinction between medical ketamine therapy and recreational misuse.

A 50-Year Safety Record

Ketamine was first synthesized in 1962 by Dr. Calvin Stevens and approved by the FDA in 1970 as a dissociative anesthetic. Since then, it has been administered millions of times worldwide in emergency departments, operating rooms, battlefield medicine, and pediatric care. Its safety profile at anesthetic doses is exceptionally well characterized.^[5]

What makes ketamine unusual among anesthetics is its wide therapeutic window -- the gap between the dose that produces the desired effect and the dose that causes serious harm. For context:

• Therapeutic dose for depression: 0.5 mg/kg IV over 40 minutes
• Anesthetic dose: 1-2 mg/kg IV (bolus)
• Lethal dose (estimated): 77-100 mg/kg in animal studies

The psychiatric dose is roughly 25-50% of the anesthetic dose, providing a substantial safety margin.

Common Side Effects

During Treatment (Acute Effects)

The side effects experienced during a ketamine infusion are predictable, dose-dependent, and temporary. They are a direct result of ketamine's pharmacological action and are managed as part of the standard clinical protocol.

Blood Pressure and Cardiovascular Effects

The most medically significant acute effect of ketamine is transient blood pressure elevation. Ketamine stimulates the sympathetic nervous system, causing:

• Systolic blood pressure: Increases 15-25 mmHg on average (peak at ~30 minutes)
• Diastolic blood pressure: Increases 10-15 mmHg on average
• Heart rate: Increases 10-20 beats per minute

These changes are comparable to moderate exercise and return to baseline within 30-60 minutes after the infusion ends. In a systematic review of ketamine safety in depression studies, no serious cardiovascular events were reported across hundreds of patients.^[2]

When cardiovascular effects become concerning:

• Blood pressure exceeding 180/110 mmHg during infusion (requires rate reduction or pause)
• Pre-existing uncontrolled hypertension (contraindication for treatment)
• History of aortic aneurysm, stroke within 6 weeks, or unstable angina
• Patients taking vasopressors or in acute heart failure

Dissociation: Therapeutic Effect, Not Just Side Effect

Dissociation during ketamine treatment is often listed as a "side effect," but it is more accurately understood as part of the therapeutic mechanism. The dissociative experience -- feeling detached from one's body, altered time perception, and shifts in self-referential processing -- correlates with the glutamate surge and default mode network changes that produce antidepressant effects.^[5]

That said, some patients find the dissociative experience unpleasant, particularly during the first session. This typically improves with subsequent sessions as patients learn what to expect and how to navigate the experience. Clinics can manage the intensity by adjusting the infusion rate.

Serious but Rare Adverse Events

Events Requiring Immediate Medical Attention

While rare, the following adverse events have been reported and are managed by clinic protocols:

Severe hypertensive episode. Blood pressure exceeding 200/120 mmHg. Managed with IV labetalol or hydralazine. Extremely rare at therapeutic doses in properly screened patients.

Laryngospasm. Involuntary closure of the vocal cords. Historically associated with pediatric anesthesia at much higher doses. Exceedingly rare at sub-anesthetic doses. Clinics have emergency airway equipment available.

Severe nausea and vomiting. While nausea is common, persistent vomiting is rare. Managed with IV ondansetron and infusion rate adjustment.

Prolonged dissociative reaction. In rare cases, the dissociative state lasts significantly longer than expected (more than 2 hours post-infusion). Managed with supportive care in the clinic until the patient returns to baseline.

Allergic reaction. True ketamine allergy is extremely rare but possible. Signs include rash, hives, facial swelling, or difficulty breathing. Clinics have epinephrine and resuscitation equipment available.

What Has NOT Been Reported in Clinical Studies

It is equally important to note what serious events have not occurred in controlled clinical trials of ketamine for depression:

• No deaths attributable to therapeutic ketamine at standard doses
• No cardiac arrest or arrhythmia events
• No seizures (ketamine actually has anticonvulsant properties)
• No permanent cognitive impairment
• No cases of ketamine-induced psychosis in properly screened patients
• No cases of bladder cystitis at therapeutic doses^[6]

Contraindications

Absolute Contraindications

The following conditions generally preclude ketamine therapy:

Uncontrolled hypertension. Blood pressure consistently above 180/100 mmHg despite medication. The additional blood pressure elevation from ketamine creates unacceptable cardiovascular risk.

Active psychosis or schizophrenia. Ketamine's NMDA receptor antagonism can transiently worsen psychotic symptoms. Patients with a history of psychotic episodes (outside of severe depression with psychotic features) are typically excluded.

Unstable aneurysmal vascular disease. The sympathomimetic effects of ketamine (blood pressure and heart rate elevation) could theoretically stress an unstable aneurysm.

Active substance use disorder involving ketamine or PCP. The risk of triggering relapse or reinforcing addictive behavior outweighs potential psychiatric benefits.

Known ketamine allergy. True allergy (not sensitivity or discomfort with side effects) is a contraindication.

Pregnancy. Insufficient data on fetal safety at sub-anesthetic doses; animal studies suggest potential neurodevelopmental concerns.

Relative Contraindications (Case-by-Case Evaluation)

Controlled hypertension. Patients whose blood pressure is well-managed on medication may be candidates with enhanced monitoring.

History of substance use disorder (in remission). Requires careful evaluation, enhanced monitoring, and often coordination with addiction medicine.

Increased intracranial pressure. Ketamine was historically thought to increase ICP, though more recent evidence suggests this may not be clinically significant at sub-anesthetic doses.

Certain types of glaucoma. Narrow-angle glaucoma may be exacerbated by ketamine's effects on intraocular pressure.

Untreated thyroid disease. Hyperthyroidism can amplify cardiovascular effects; should be managed before starting treatment.

Bipolar disorder (mania risk). While ketamine treats bipolar depression effectively, there is a theoretical risk of triggering a manic episode. Most clinics proceed with mood stabilizer protection.

Drug Interactions

Medications That Affect Ketamine Safety or Efficacy

Substances to Avoid

Alcohol. Avoid for 24 hours before and after treatment. Both ketamine and alcohol depress the central nervous system. The combination can cause dangerous respiratory depression and amplified cognitive impairment.

Cannabis/THC. While not dangerous in the acute sense, cannabis can alter the ketamine experience unpredictably and may interfere with integration. Most providers recommend abstaining for 24 hours before and after sessions.

Recreational drugs. MDMA, cocaine, amphetamines, and other recreational substances can interact with ketamine in dangerous and unpredictable ways. Complete abstinence from recreational substances during ketamine therapy is essential.

St. John's Wort. This herbal supplement affects multiple CYP enzyme systems and can alter ketamine metabolism. Discontinue 1-2 weeks before starting therapy.

Risk Factors for Adverse Events

Who Is at Higher Risk?

Certain patient populations require enhanced monitoring or modified protocols:

Cardiovascular disease. Patients with controlled hypertension, stable coronary artery disease, or arrhythmia history should be treated in facilities with cardiac monitoring capabilities and emergency cardiac medications available.

Elderly patients (65+). Age-related changes in drug metabolism may require dose adjustment. Blood pressure responses may be less predictable. The TRANSFORM-3 trial in elderly patients showed safety but lower efficacy.

History of substance abuse. Even in remission, these patients should be monitored more closely for signs of inappropriate use, craving, or drug-seeking behavior.

Liver disease. Ketamine is hepatically metabolized. Significant liver impairment may alter drug clearance, requiring dose adjustment and liver function monitoring.

Obese patients. Dosing based on ideal body weight rather than actual body weight is recommended for patients with BMI above 30, as adipose tissue affects drug distribution.

Medical Ketamine vs. Recreational Misuse: A Critical Distinction

One of the most significant barriers to patients seeking ketamine therapy is the stigma associated with ketamine as a "party drug." The distinction between medical and recreational use is profound:

Dosage

• Medical: 0.5 mg/kg IV (35 mg for a 70 kg person) delivered over 40 minutes
• Recreational: 100-500+ mg snorted, injected, or swallowed, often repeatedly in a single session
• Difference: Recreational doses are typically 3-15x higher and delivered much more rapidly

Frequency

• Medical: 2-3 sessions per week during initial series, then monthly or less for maintenance
• Recreational: Can be daily or multiple times per week
• Difference: Medical use involves intermittent, controlled dosing; recreational use often involves frequent, uncontrolled use

Setting and Monitoring

• Medical: Sterile clinical environment with continuous vital sign monitoring, emergency medications available, trained medical staff present
• Recreational: Uncontrolled environments, no monitoring, no medical support, often combined with other substances
• Difference: Medical settings provide every safety measure; recreational settings provide none

Purity and Source

• Medical: Pharmaceutical-grade ketamine with known concentration, no contaminants
• Recreational: Street-sourced with unknown purity, often cut with other substances
• Difference: Medical ketamine is exactly what it says it is; street ketamine may contain fentanyl, methamphetamine, or other dangerous adulterants

Associated Harms

The serious harms associated with ketamine -- bladder damage (ketamine cystitis), cognitive impairment, liver toxicity, psychological dependence -- occur primarily in the context of chronic heavy recreational use:^[6][7]

| Harm | Recreational Use | Therapeutic Use | |------|-----------------|-----------------| | Bladder cystitis | Documented in chronic users | Not reported at therapeutic doses | | Cognitive impairment | Documented in heavy users | Not found in clinical studies | | Liver toxicity | Reported with chronic heavy use | Not reported at therapeutic doses | | Psychological dependence | 20-30% of chronic users | Rare with clinical protocols | | Nasal damage | Common with chronic snorting | N/A (IV or supervised nasal spray) |

Monitoring Protocols in Quality Clinics

A well-run ketamine clinic follows these safety protocols for every session:

Before Treatment

• Vital signs (blood pressure, heart rate, oxygen saturation)
• Review of medications taken that day
• Assessment of current psychiatric state
• Confirmation of transportation arrangements
• Review of fasting compliance

During Treatment

• Continuous pulse oximetry
• Blood pressure every 5-15 minutes
• Visual assessment of breathing, comfort, and consciousness
• Clinician available to adjust infusion rate
• Emergency medications and equipment immediately accessible

After Treatment

• Vital signs every 10-15 minutes until baseline
• Coordination and orientation assessment
• Nausea management if needed
• Verification of stable condition before discharge
• Confirmation of ride home

Periodic Monitoring (Long-Term Maintenance)

• Liver function tests every 6-12 months
• Blood pressure trends across sessions
• Cognitive assessment if concerns arise
• Screening for substance misuse
• Review of urinary symptoms

What a Safe Clinic Looks Like

When choosing a ketamine provider, use these safety indicators to evaluate the clinic:

Green flags:

• Board-certified physician oversight (psychiatrist, anesthesiologist, or emergency medicine)
• Comprehensive intake evaluation with psychiatric and medical screening
• Pre-treatment vital signs and fasting verification at every session
• Continuous monitoring during infusion
• Emergency medications and equipment on site
• Structured post-treatment observation period
• Follow-up assessment protocols with standardized rating scales
• Transparent informed consent process

Red flags:

• No physician on site or on call during treatments
• No vital sign monitoring during infusion
• No screening for contraindications
• Treatment provided without a comprehensive intake evaluation
• Pressure to commit to expensive, long-term treatment packages upfront
• Claims of "guaranteed" results
• Willingness to treat anyone regardless of contraindications

For help finding a reputable provider, use our clinic directory and review our guide on questions to ask a ketamine clinic.

Summary

Ketamine therapy has a well-established safety profile built on 50+ years of clinical use and hundreds of controlled studies. When administered by qualified providers with proper screening and monitoring, the risks are manageable and the serious adverse events are rare. The most important safety factors are: proper patient selection (screening out contraindications), appropriate medical monitoring during treatment, and choosing a reputable clinic with trained staff.

The gap between medical ketamine therapy and recreational misuse is as wide as the gap between prescription opioid pain management and heroin use -- same class of molecule, vastly different risk profiles based on dose, setting, supervision, and purity.

To understand how ketamine works in your brain, read about the mechanism of action. For evidence from clinical research, see our clinical trials overview.